I think the lifting of the hold is more significant than you think. we all tend to think in terms of events occurring in a series order, however the number of parallel processes are numerous. i don't think the whole world of potential partners on any indications are waiting for the clinical hold to lift before they press send on the email asking if Cytodyn want to team up with them. They are already talking and have been this whole time. many might say they won't be interested until the hold is lifted, many likely make low-ball offers because there is a clinical hold and they want to try and get in for cheap and before someone else snatches it up.
What does Cytodyn do in this situation? if they have no partnerships of any kind and we are days or weeks away from it being lifted (hopefully), i would think that is a sign that Cytodyn is not going to partner until the hold is lifted. They can scrape along for a long time, they have gone into hibernation. This means the buyout/partnership offer needs to be a no clinical hold problem level dollar amount.
This means the clinical hold is the wall that once climbed, opens the doors to all potential deals being possible. Stock price is based on potential, not actual value. todays stock price is extremally low because all future is on hold and may never happen. with no clinical hold, all future potential can happen. We were at the $1-$3 stock price when this company was in trials and the future of approvals were within grasp. as soon as we got the RTF letter, all potential was lost. the hold lifting corrects for that.